These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11940977)

  • 21. [Post-radiation effect on the interhemispheric asymmetry in EEG and thermography characteristics].
    Zhavoronkova LA; Gabova AV; Kuznetsova GD; Sel'skiĭ AG; Pasechnik VI; Kholodova NB; Ianovich AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(4):410-9. PubMed ID: 14598548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive functions after only one ECT session: a controlled study.
    Rami L; Goti J; Ferrer J; Marcos T; Salamero M; Bernardo M
    Psychiatry Res; 2008 Apr; 158(3):389-94. PubMed ID: 18279973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective Side Effects Acutely Following ECT: Associations with Treatment Modality and Clinical Response.
    Sackeim HA; Ross FR; Hopkins N; Calev L; Devanand DP
    Convuls Ther; 1987; 3(2):100-110. PubMed ID: 11940903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Baghai TC; Marcuse A; Brosch M; Schüle C; Eser D; Nothdurfter C; Steng Y; Noack I; Pietschmann K; Möller HJ; Rupprecht R
    World J Biol Psychiatry; 2006; 7(2):82-90. PubMed ID: 16684680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients.
    Bajbouj M; Lang UE; Niehaus L; Hellen FE; Heuser I; Neu P
    J Psychiatr Res; 2006 Jun; 40(4):322-7. PubMed ID: 16137698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biogenic Amine Metabolites During Electroconvulsive Therapy of Melancholic Patients.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Convuls Ther; 1990; 6(4):266-272. PubMed ID: 11941079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory performance in severely depressed patients treated by electroconvulsive therapy.
    Hihn H; Baune BT; Michael N; Markowitsch H; Arolt V; Pfleiderer B
    J ECT; 2006 Sep; 22(3):189-95. PubMed ID: 16957535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.
    Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
    Bipolar Disord; 2009 Jun; 11(4):418-24. PubMed ID: 19500095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visuospatial deficits in patients with early left-hemispheric lesions and functional reorganization of language: consequence of lesion or reorganization?
    Lidzba K; Staudt M; Wilke M; Krägeloh-Mann I
    Neuropsychologia; 2006; 44(7):1088-94. PubMed ID: 16313931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance Electroconvulsive Therapy and Seizure Duration.
    Jarvis MR; Zorumski CF; Goewert AJ; Rasmussen KG
    Convuls Ther; 1993; 9(1):8-13. PubMed ID: 11941186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term cognitive and behavioural follow-up in three patients with eye closure-triggered paroxysmal activity.
    Termine C; Teutonico F; Balottin U; Fasce M; Ferri M; Perna S; Piccinelli P; Rubboli G; Veggiotti P
    Epileptic Disord; 2008 Mar; 10(1):22-30. PubMed ID: 18367428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of Clinical Spectrum for Mechanisms of Action: ECT and Antidepressants Reconsidered.
    Lichtenberg P; Lerer B
    Convuls Ther; 1989; 5(3):216-226. PubMed ID: 11941021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related cognitive effects of ECT and ECT-induced mood improvement in depressive patients.
    Bosboom PR; Deijen JB
    Depress Anxiety; 2006; 23(2):93-101. PubMed ID: 16400627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT.
    Loo C; Sheehan P; Pigot M; Lyndon W
    J Affect Disord; 2007 Nov; 103(1-3):277-81. PubMed ID: 17706790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
    Matthews JD; Blais M; Park L; Welch C; Baity M; Murakami J; Sklarsky K; Homberger C; Fava M
    J Psychiatr Res; 2008 Jun; 42(7):526-31. PubMed ID: 17681545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy.
    Sawayama E; Takahashi M; Inoue A; Nakajima K; Kano A; Sawayama T; Okutomi T; Miyaoka H
    J ECT; 2008 Sep; 24(3):195-8. PubMed ID: 18772703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression.
    Eschweiler GW; Vonthein R; Bode R; Huell M; Conca A; Peters O; Mende-Lechler S; Peters J; Klecha D; Prapotnik M; DiPauli J; Wild B; Plewnia C; Bartels M; Schlotter W
    J Affect Disord; 2007 Aug; 101(1-3):149-57. PubMed ID: 17196664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.